BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sabnis A, Hagart KL, Klöckner A, Becce M, Evans LE, Furniss RCD, Mavridou DA, Murphy R, Stevens MM, Davies JC, Larrouy-Maumus GJ, Clarke TB, Edwards AM. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. Elife 2021;10:e65836. [PMID: 33821795 DOI: 10.7554/eLife.65836] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Mohapatra SS, Dwibedy SK, Padhy I. Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions. J Biosci 2021;46. [DOI: 10.1007/s12038-021-00209-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Manzo G, Gianfanti F, Hind CK, Allison L, Clarke M, Hohenbichler J, Limantoro I, Martin B, Do Carmo Silva P, Ferguson PM, Hodgson-Casson AC, Fleck RA, Sutton JM, Phoenix DA, Mason AJ. Impacts of Metabolism and Organic Acids on Cell Wall Composition and Pseudomonas aeruginosa Susceptibility to Membrane Active Antimicrobials. ACS Infect Dis 2021;7:2310-23. [PMID: 34329558 DOI: 10.1021/acsinfecdis.1c00002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Valcourt C, Buyck JM, Grégoire N, Couet W, Marchand S, Tewes F. Lipid Nanoparticles Loaded with Farnesol or Geraniol to Enhance the Susceptibility of E. coli MCR-1 to Colistin. Pharmaceutics 2021;13:1849. [PMID: 34834268 DOI: 10.3390/pharmaceutics13111849] [Reference Citation Analysis]
4 Tiwari V, Panta PR, Billiot CE, Douglass MV, Herrera CM, Trent MS, Doerrler WT. A Klebsiella pneumoniae DedA family membrane protein is required for colistin resistance and for virulence in wax moth larvae. Sci Rep 2021;11:24365. [PMID: 34934166 DOI: 10.1038/s41598-021-03834-3] [Reference Citation Analysis]
5 Panta PR, Doerrler WT. A link between pH homeostasis and colistin resistance in bacteria. Sci Rep 2021;11:13230. [PMID: 34168215 DOI: 10.1038/s41598-021-92718-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Elias R, Duarte A, Perdigão J. A Molecular Perspective on Colistin and Klebsiella pneumoniae: Mode of Action, Resistance Genetics, and Phenotypic Susceptibility. Diagnostics (Basel) 2021;11:1165. [PMID: 34202395 DOI: 10.3390/diagnostics11071165] [Reference Citation Analysis]
7 Zik JJ, Yoon SH, Guan Z, Stankeviciute Skidmore G, Gudoor RR, Davies KM, Deutschbauer AM, Goodlett DR, Klein EA, Ryan KR. Caulobacter lipid A is conditionally dispensable in the absence of fur and in the presence of anionic sphingolipids. Cell Rep 2022;39:110888. [PMID: 35649364 DOI: 10.1016/j.celrep.2022.110888] [Reference Citation Analysis]
8 Mohamed Abu El-Wafa W, Abouwarda AM. In vitro assessment of the antibacterial effects of the combinations of fosfomycin, colistin, trimethoprim and nitrofurantoin against multi-drug-resistant Escherichia coli. Lett Appl Microbiol 2021. [PMID: 34839528 DOI: 10.1111/lam.13619] [Reference Citation Analysis]
9 Li H, Mattingly AE, Jania LA, Smith R, Melander RJ, Ernst RK, Koller BH, Melander C. Benzimidazole Isosteres of Salicylanilides Are Highly Active Colistin Adjuvants. ACS Infect Dis 2021;7:3303-13. [PMID: 34752055 DOI: 10.1021/acsinfecdis.1c00463] [Reference Citation Analysis]
10 Seipke RF. Antibiotics made to order. Science 2022;376:919-20. [PMID: 35617396 DOI: 10.1126/science.abq3206] [Reference Citation Analysis]
11 Ilangumaran Ponmalar I, Swain J, Basu JK. Escherichia coli response to subinhibitory concentrations of colistin: insights from a study of membrane dynamics and morphology. Biomater Sci 2022. [PMID: 35411890 DOI: 10.1039/d2bm00037g] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bray AS, Smith RD, Hudson AW, Hernandez GE, Young TM, George HE, Ernst RK, Zafar MA. MgrB-Dependent Colistin Resistance in Klebsiella pneumoniae Is Associated with an Increase in Host-to-Host Transmission. mBio 2022;:e0359521. [PMID: 35311534 DOI: 10.1128/mbio.03595-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Weerakoon D, Petrov K, Pedebos C, Khalid S. Polymyxin B1 within the E. coli cell envelope: insights from molecular dynamics simulations. Biophys Rev 2021;13:1061-70. [PMID: 35047090 DOI: 10.1007/s12551-021-00869-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 De Oliveira DMP, Keller B, Hayes AJ, Ong CY, Harbison-price N, El-deeb IM, Li G, Keller N, Bohlmann L, Brouwer S, Turner AG, Cork AJ, Jones TR, Paterson DL, Mcewan AG, Davies MR, Mcdevitt CA, Itzstein MV, Walker MJ. Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria. Antibiotics 2022;11:449. [DOI: 10.3390/antibiotics11040449] [Reference Citation Analysis]
15 Abdelhamid AG, Campbell EP, Hawkins Z, Yousef AE. Efficient Production of Broad-Spectrum Antimicrobials by Paenibacillus polymyxa OSY–EC Using Acid Whey-Based Medium and Novel Antimicrobial Concentration Approach. Front Bioeng Biotechnol 2022;10:869778. [DOI: 10.3389/fbioe.2022.869778] [Reference Citation Analysis]
16 Ledger EVK, Sabnis A, Edwards AM. Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort. Microbiology (Reading) 2022;168. [PMID: 35118938 DOI: 10.1099/mic.0.001136] [Reference Citation Analysis]
17 Giles SK, Stroeher UH, Papudeshi B, Edwards RA, Carlson-jones JA, Roach M, Brown MH. The StkSR Two-Component System Influences Colistin Resistance in Acinetobacter baumannii. Microorganisms 2022;10:985. [DOI: 10.3390/microorganisms10050985] [Reference Citation Analysis]
18 Brown AN, Anderson MT, Bachman MA, Mobley HLT. The ArcAB Two-Component System: Function in Metabolism, Redox Control, and Infection. Microbiol Mol Biol Rev 2022;:e0011021. [PMID: 35442087 DOI: 10.1128/mmbr.00110-21] [Reference Citation Analysis]
19 Sun Z, Palzkill T. Deep Mutational Scanning Reveals the Active-Site Sequence Requirements for the Colistin Antibiotic Resistance Enzyme MCR-1. mBio 2021;:e0277621. [PMID: 34781730 DOI: 10.1128/mBio.02776-21] [Reference Citation Analysis]
20 Cervoni M, Lo Sciuto A, Bianchini C, Mancone C, Imperi F. Exogenous and Endogenous Phosphoethanolamine Transferases Differently Affect Colistin Resistance and Fitness in Pseudomonas aeruginosa. Front Microbiol 2021;12:778968. [PMID: 34777328 DOI: 10.3389/fmicb.2021.778968] [Reference Citation Analysis]
21 Janssen AB, Doorduijn DJ, Mills G, Rogers MRC, Bonten MJM, Rooijakkers SHM, Willems RJL, Bengoechea JA, van Schaik W. Evolution of Colistin Resistance in the Klebsiella pneumoniae Complex Follows Multiple Evolutionary Trajectories with Variable Effects on Fitness and Virulence Characteristics. Antimicrob Agents Chemother 2020;65:e01958-20. [PMID: 33139278 DOI: 10.1128/AAC.01958-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Sabnis A, Hagart KL, Klöckner A, Becce M, Evans LE, Furniss RCD, Mavridou DA, Murphy R, Stevens MM, Davies JC, Larrouy-Maumus GJ, Clarke TB, Edwards AM. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. Elife 2021;10:e65836. [PMID: 33821795 DOI: 10.7554/eLife.65836] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
23 Viehweger A, Blumenscheit C, Lippmann N, Wyres KL, Brandt C, Hans JB, Hölzer M, Irber L, Gatermann S, Lübbert C, Pletz MW, Holt KE, König B. Context-aware genomic surveillance reveals hidden transmission of a carbapenemase-producing Klebsiella pneumoniae. Microb Genom 2021;7. [PMID: 34913861 DOI: 10.1099/mgen.0.000741] [Reference Citation Analysis]
24 Thomas GH. Microbial Musings - November 2021. Microbiology (Reading) 2022;167. [PMID: 35019835 DOI: 10.1099/mic.0.001134] [Reference Citation Analysis]
25 Xu C, Liu C, Chen K, Zeng P, Chan EWC, Chen S. Otilonium bromide boosts antimicrobial activities of colistin against Gram-negative pathogens and their persisters. Commun Biol 2022;5:613. [PMID: 35729200 DOI: 10.1038/s42003-022-03561-z] [Reference Citation Analysis]
26 Sweeney E, Sabnis A, Edwards AM, Harrison F. Effect of host-mimicking medium and biofilm growth on the ability of colistin to kill Pseudomonas aeruginosa. Microbiology (Reading) 2020;166:1171-80. [PMID: 33253080 DOI: 10.1099/mic.0.000995] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Zhang Q, Chen S, Liu X, Lin W, Zhu K. Equisetin Restores Colistin Sensitivity against Multi-Drug Resistant Gram-Negative Bacteria. Antibiotics (Basel) 2021;10:1263. [PMID: 34680843 DOI: 10.3390/antibiotics10101263] [Reference Citation Analysis]
28 Acharya Y, Bhattacharyya S, Dhanda G, Haldar J. Emerging Roles of Glycopeptide Antibiotics: Moving beyond Gram-Positive Bacteria. ACS Infect Dis 2022;8:1-28. [PMID: 34878254 DOI: 10.1021/acsinfecdis.1c00367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]